These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32506921)

  • 21. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
    Patel K; Kabir R; Ahmad S; Allen SL
    J Oncol Pharm Pract; 2016 Apr; 22(2):212-8. PubMed ID: 25326010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
    Chuang YC; Wang JT; Lin HY; Chang SC
    BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature.
    Li F; Wang Y; Sun L; Wang X
    BMC Infect Dis; 2020 Feb; 20(1):167. PubMed ID: 32087689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
    J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia.
    Ye JJ; Shie SS; Cheng CW; Yang JH; Huang PY; Wu TS; Lee MH; Huang CT
    J Microbiol Immunol Infect; 2018 Dec; 51(6):705-716. PubMed ID: 29046248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
    Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
    Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an
    Belley A; Lalonde-Séguin D; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature.
    Bender JK; Cattoir V; Hegstad K; Sadowy E; Coque TM; Westh H; Hammerum AM; Schaffer K; Burns K; Murchan S; Novais C; Freitas AR; Peixe L; Del Grosso M; Pantosti A; Werner G
    Drug Resist Updat; 2018 Sep; 40():25-39. PubMed ID: 30447411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.
    Herc ES; Kauffman CA; Marini BL; Perissinotti AJ; Miceli MH
    Leuk Lymphoma; 2017 Dec; 58(12):2852-2858. PubMed ID: 28402152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review.
    Shaikh ZH; Peloquin CA; Ericsson CD
    Scand J Infect Dis; 2001; 33(5):375-9. PubMed ID: 11440224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series.
    Russo A; Venditti M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106432. PubMed ID: 34525403
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of vancomycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy.
    Shea K; Hilburger E; Baroco A; Oldfield E
    Ann Pharmacother; 2008 May; 42(5):722-5. PubMed ID: 18349306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model.
    Meyer KA; Deraedt MF; Harrington AT; Danziger LH; Wenzler E
    Int J Antimicrob Agents; 2019 Aug; 54(2):197-201. PubMed ID: 31034937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.
    Kanchanapoom T; Koirala J; Goodrich J; Agamah E; Khardori N
    Diagn Microbiol Infect Dis; 2003 Mar; 45(3):213-5. PubMed ID: 12663164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.